In the News: Anatomy of a Scam

January 16, 2017 by C. Scott McMillin

Medicare spending on compounded topical drugs has surged 3400% since 2006.

Topics: ,


NarCan’t?

January 2, 2017 by C. Scott McMillin

To support revenues, companies look for ways to augment or alter older products and justify price increases.

Topics: , ,


The View Depends on Where You Stand

December 26, 2016 by C. Scott McMillin

This isn’t a problem a physician can deal with comfortably in the context of a 12-15 minute office visit.

Topics: , , ,


Suboxone and Overdose

December 8, 2016 by C. Scott McMillin

Naloxone is there to prevent someone from injecting Suboxone to get high.

Topics: , , , ,


Oliver on Opioids

November 7, 2016 by C. Scott McMillin

It’s hard to accept that what began in an effort to help people in pain has turned into this unholy mess.

Topics: , ,


In the News: Adderall Angst

October 17, 2016 by C. Scott McMillin

“I probably would have taken them anyway. I was really hoping for a chemical fix.”

Topics: ,


Opioid Prescribing in an Opioid Epidemic

October 13, 2016 by C. Scott McMillin

Just tracking alone seems to significantly reduce reliance on opioids.

Topics: ,


In the News (again… still…): Pill Mills

October 6, 2016 by C. Scott McMillin

So-called “Dr. Feelgoods” have been around for as long as I can remember.

Topics: ,


Revisiting the Politics of Painkillers

September 26, 2016 by C. Scott McMillin

Despite the collateral damage, Big Pharma seems determined to preserve the market for its products, through sophisticated lobbying.

Topics: , , ,


Pharmaceutical “Cures”

September 22, 2016 by C. Scott McMillin

From a patient’s viewpoint, physicians can be somewhat blase’ about risks associated with a medication.

Topics: ,


Subscribe to RecoverySI via Email


New Content